Richard Pops

14 results

Richard Pops, chairman and chief executive officer of Alkermes. Photograph: Patrick  Fallon/Bloomberg

Irish drug group Alkermes has reported a 15 per cent rise in revenues for the fourth quarter. Sales jumped to $315.8 million in the fourth quarter. T(...)

Alkermes chief executive Richard Pops said he was disappointed by the vote of the FDA advisory panel on its new drug for major depressive disorder. Photograph: Dara Mac Dónaill

An advisory panel to the US Food and Drug Administration voted against approving a treatment for depression developed by Irish-based company Alkermes (...)

Alkermes reckons more than eight million people in the US alone suffer from a major depressive disorder. File photograph: Getty Images

Shares in Irish biopharma group Alkermes jumped sharply after the United States Food and Drug Administration (FDA) agreed to reconsider a depression d(...)

Richard Pops, chairman and chief executive officer of Alkermes. Photograph: Patrick Fallon/Bloomberg

Shares in Irish drug company Alkermes continued to slide as the company comes to terms with an FDA refusal to consider approval for a depression drug (...)

Richard Pops, Alkermes chief executive, received a lower salary last year. Photograph: Dara Mac Dónaill / The Irish Times

Executives at Irish-headquartered biopharma group Alkermes received lower overall remuneration last year. The group, which is domiciled in Ireland fo(...)

Richard Pops, chief executive  of Alkermes at their Dublin offices. Photograph: Aidan Crawley

Revenue at Irish drug group Alkermes jumped almost 24 per cent in the first three months of the year, to $161.2 million, ahead of analyst expectations(...)

Richard Pops, chief executive  of Alkermes in their Dublin offices. Photograph: Aidan Crawley

Biopharma group Alkermes has reported fourth-quarter earnings and revenues that beat expectations. However, it fell to a full-year loss on generally (...)

Richard Pops, Alkermes chief executive, says that the company is not interested in being bought out as it nears the launch of new drugs.Photograph: Dara Mac Dónaill / THE IRISH TIMES

Dublin-based Alkermes has the low-tax domicile currently in vogue among multinational pharmaceutical companies but is not interested in being bought o(...)

Alkermes chief executive Richard Pops. Photograph: Dara Mac Dónaill / THE IRISH TIMES

Shares in Irish drug company Alkermes jumped over 10 per cent yesterday after it announced plans to seek US marketing approval for its experime(...)

Richard Pops, Alkermes chief executive, Photograph: Dara Mac Dónaill / The Irish Times

Irish biopharma group Alkermes has reported record revenues for 2013 and forecast a strong year ahead for drugs at an a(...)

  • 1
  • 2
  • Next
  • Last »